We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBE SCIENTIFIC, LLC

Download Mobile App




New Breathalyzer Monitors Blood Glucose in Diabetics

By LabMedica International staff writers
Posted on 26 Nov 2013
A novel noninvasive breathalyzer device has been created that can monitor blood glucose levels in diabetics by detecting acetone levels. More...


Current technology to measure blood glucose includes the use of a portable testing meter that can measure sugar levels in the body from a small drop of blood, but it is invasive, can often cause discomfort for the patient, and can lead to low compliance with poor health consequences.

Scientists at the Western New England University (Springfield, MA, USA) produced a hand-held breathalyzer that uses nanometer-thick films that are made up of two polymers. These polymers are able to react with acetone. Acetone is one of the ketones, which are acids that remain in the body when the body burns its own fat. Ketones build up when there is not enough insulin to help fuel the body's cells, meaning they are more common in people with diabetes.

In the breathalyzer device, the acetone adheres to the polymers and alters the physical chemistry of the film. The film then discloses the amount of acetone detected, which in turn reveals glucose levels in the blood. At present, the breathalyzer is similar in size to a book; however, an engineer at Western New England University is helping to make the device similar in size to breathalyzers that are used to detect blood alcohol content levels.

Ronny Priefer, PhD, the designer of the device said, “Breathalyzers are a growing field of study because of their potential to have a significant positive impact on patients' quality of life and compliance with diabetes monitoring. What makes our technology different is that it only accounts for acetone and doesn't react with other components in the breath.”

Prof. Preifer added that common shortfalls with other breathalyzer technologies have included inconsistent results due to natural humidity in the breath, high temperature requirements, and lack of differentiation. The study was presented at the American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition held November 10-14, 2013, in San Antonio (TX, USA).

Related Links:

Western New England University




Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Droplet Digital PCR System
QX600 AutoDG
New
Toxoplasma Gondii Test
Toxo IgG ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The precision oncology test identifies patients most at risk of undergoing severe toxicity from treatment with 5FU/capecitabine (Photo courtesy of 123RF)

Precision Oncology Test Predicts Patient Toxicity Before Beginning Chemotherapy

5-fluorouracil (5FU) and capecitabine have been cornerstone chemotherapeutic agents for over four decades, effectively treating a variety of cancers. However, 5FU/capecitabine can cause varying degrees... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: Custom hardware and software for the real-time detection of immune cell biophysical signatures in NICU (Photo courtesy of Pediatric Research, DOI:10.1038/s41390-025-03952-y)

First-Of-Its-Kind Device Profiles Newborns' Immune Function Using Single Blood Drop

Premature infants are highly susceptible to severe and life-threatening conditions, such as sepsis and necrotizing enterocolitis (NEC). Newborn sepsis, which is a bloodstream infection occurring in the... Read more

Pathology

view channel
Image: Mimix Reference Standards are cell-line derived to maintain genomic complexity and mimic patient material across molecular diagnostics workflows (Photo courtesy of Revvity)

New Cancer Testing Standards to Improve Diagnostic Accuracy for Oncology Labs

Accurate diagnosis, including the identification of genomic markers, is essential for determining the most effective cancer treatments for patients. To ensure this, laboratories require reliable reference... Read more

Technology

view channel
Image: The machine learning-based method delivers near-perfect survival estimates for PAC patients (Photo courtesy of Shutterstock)

AI Method Predicts Overall Survival Rate of Prostate Cancer Patients

Prostate adenocarcinoma (PAC) accounts for 99% of prostate cancer diagnoses and is the second most common cancer in men globally after skin cancer. With more than 3.3 million men in the United States diagnosed... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.